Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant
Main Authors: | Mary Kathryn Abel, AB, Alyssa Gwen Ashbaugh, Jenny E. Murase, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | International Journal of Women's Dermatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352647521000794 |
Similar Items
-
Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant
by: Ruby S. Gibson, MD, et al.
Published: (2021-09-01) -
Biologic therapy use and pregnancy outcomes in women with immune-mediated inflammatory rheumatic diseases
by: Luisa Brites, et al.
Published: (2019-10-01) -
Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road
by: Asmaa Beltagy, et al.
Published: (2021-02-01) -
Pregnancy and Cancer: Cellular Biology and Mechanisms Affecting the Placenta
by: Melina de Moraes Santos Oliveira, et al.
Published: (2021-04-01) -
Management of rheumatoid arthritis during pregnancy: challenges and solutions
by: Krause ML, et al.
Published: (2016-03-01)